Use of adenovirus type-5 vectored vaccines: a cautionary tale.

Szczegóły
Comments

Tytuł :: Use of adenovirus type-5 vectored vaccines: a cautionary tale.
Autorzy :: Buchbinder SP; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA 94102, USA; Department of Medicine and Department of Epidemiology, University of California, San Francisco, CA, USA. Electronic address: .
McElrath MJ; Fred Hutchinson Cancer Research Institute, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, University of Washington, Seattle, WA, USA.
Dieffenbach C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Corey L; Fred Hutchinson Cancer Research Institute, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, University of Washington, Seattle, WA, USA.; Pokaż więcej
Źródło :: Lancet (London, England) [Lancet] 2020 Oct 31; Vol. 396 (10260), pp. e68-e69. Date of Electronic Publication: 2020 Oct 19.
Typ publikacji :: Letter; Comment
Język :: English
Imprint Name(s) :: Publication: 2004- : London : Elsevier
Original Publication: London : J. Onwhyn
MeSH Terms :: Adenovirus Vaccines*
Coronavirus Infections*/prevention & control
Pandemics*
Pneumonia, Viral*
Viral Vaccines*
Adenoviridae/genetics ; Betacoronavirus ; COVID-19 ; COVID-19 Vaccines ; Genetic Vectors ; Humans ; SARS-CoV-2 ; Vaccines, Synthetic
References :: J Infect Dis. 2012 Jul 15;206(2):258-66. (PMID: 22561365)
PLoS One. 2015 Sep 14;10(9):e0137666. (PMID: 26368824)
Lancet. 2008 Nov 29;372(9653):1894-1905. (PMID: 19012957)
J Virol. 2012 Feb;86(4):2239-50. (PMID: 22156519)
J Exp Med. 2008 Nov 24;205(12):2717-25. (PMID: 18981239)
N Engl J Med. 2013 Nov 28;369(22):2083-92. (PMID: 24099601)
J Clin Invest. 2012 Jan;122(1):359-67. (PMID: 22201684)
Lancet. 2008 Nov 29;372(9653):1881-1893. (PMID: 19012954)
Lancet Infect Dis. 2011 Jul;11(7):507-15. (PMID: 21570355)
Science. 2014 Apr 4;344(6179):49-51. (PMID: 24700849)
PLoS One. 2014 Sep 30;9(9):e108954. (PMID: 25268493)
PLoS Pathog. 2018 Feb 23;14(2):e1006888. (PMID: 29474461)
Lancet. 2020 Jun 13;395(10240):1845-1854. (PMID: 32450106)
Substance Nomenclature :: 0 (Adenovirus Vaccines)
0 (COVID-19 Vaccines)
0 (Vaccines, Synthetic)
0 (Viral Vaccines)
Entry Date(s) :: Date Created: 20201022 Date Completed: 20201111 Latest Revision: 20210110
Update Code :: 20210110
PubMed Central ID :: PMC7571904
DOI :: 10.1016/S0140-6736(20)32156-5
PMID :: 33091364
: Opinia redakcyjna

Full Text Finder

Comment on: Lancet. 2020 Jun 13;395(10240):1845-1854. (PMID: 32450106)

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu